Literature DB >> 2744351

Endoscopic laser treatment for rectosigmoid villous adenoma: factors affecting the results.

J M Brunetaud1, V Maunoury, D Cochelard, B Boniface, A Cortot, J C Paris.   

Abstract

Endoscopic laser treatment is reported in 264 patients with benign rectosigmoid villous adenomas revealed by biopsy. Patients include 100 who had contraindications to surgery, 60 who had a tumor recurrence after a nonlaser treatment, 101 for whom surgical resection appeared to be too drastic for a tumor found benign on biopsy, and 3 who refused surgery. Two types of lasers were used: the Nd:YAG and the argon laser. In some patients, both lasers were used. Treatment was completed in 226 patients. Total tumor destruction was attained in 92% of them, a carcinoma was detected in 7% on biopsy specimens obtained during laser treatment, and benign villous tissue persisted in 1%. During the average 25.9-mo follow-up period of the patients with total tumor destruction, 13% had a tumor recurrence. Treatment was well-tolerated with no major complications. The circumferential extension of the tumor base was the only factor affecting the duration of treatment, and the rate of complications. The recurrence rate after initial treatment was higher in patients treated for a recurrence after a previous nonlaser treatment than in patients treated only by laser (p = 0.04). It was also higher when the initial histology was low-grade dysplasia than if it was high-grade dysplasia (p = 0.017) and when the tumor was located in the lower or middle rectum as opposed to the upper rectum or sigmoid (p = 0.04). We estimated that the direct cost of laser treatments was 28%-40% of the surgery charges for lesions of identical size in our hospital and 31%-69% at UCLA Center for the Health Sciences. Because treatment is long and difficult and the cancer rate is high, endoscopic laser for patients with a circumferential villous adenoma should be limited to nonsurgical candidates. The risk of a fatal complication after surgery has to be balanced against the risk of undetected carcinoma in the other patients and the indication for endoscopic laser treatment should be discussed case by case.

Entities:  

Mesh:

Year:  1989        PMID: 2744351     DOI: 10.1016/0016-5085(89)90061-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

1.  You light up my life ... and liver. Gastroenterologic laser therapy in the 1990s.

Authors:  R A Kozarek
Journal:  West J Med       Date:  1992-07

2.  Endorectal sonography in the management of rectal villous tumours.

Authors:  H Mosnier; M Guivarc'h; B Meduri; J Fritsch; F Outters
Journal:  Int J Colorectal Dis       Date:  1990-05       Impact factor: 2.571

3.  Severe acute pancreatitis following laser treatment of periampullary villous adenoma.

Authors:  V Maunoury; J M Brunetaud; H Ghisbain; B Leroy; A Saudemont; A Cortot; P Quandalle; J C Paris
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

4.  Prophylactic Snare Tip Soft Coagulation and Its Impact on Adenoma Recurrence After Colonic Endoscopic Mucosal Resection.

Authors:  Pujan Kandel; Monia E Werlang; Issac R Ahn; Timothy A Woodward; Massimo Raimondo; Ernest P Bouras; Michael B Wallace; Victoria Gómez
Journal:  Dig Dis Sci       Date:  2019-05-16       Impact factor: 3.199

Review 5.  Therapeutic colonoscopy.

Authors:  K A Forde
Journal:  World J Surg       Date:  1992 Nov-Dec       Impact factor: 3.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.